Long-term anticoagulant therapy is essential for stroke prevention among patients with atrial fibrillation, but increasing evidence also points to substantial risk for adverse events, especially when anticoagulation is temporarily interrupted.1,2 The recently published Effectiveness of Bridging Anticoagulation for Surgery Trial confirmed prior observational evidence that using short-acting anticoagulants periprocedurally increases bleeding risk without any reduction in stroke risk.3 Little is known about how medical specialists coordinate the complex decision of which patients to bridge. To investigate this question, we conducted a regional multispecialty, multicenter survey study regarding bridging practices.
Barnes GD, Kurlander J, Haymart B, Kaatz S, Saini S, Froehlich JB. Bridging Anticoagulation Before ColonoscopyResults of a Multispecialty Clinician Survey. JAMA Cardiol. 2016;1(9):1076-1077. doi:10.1001/jamacardio.2016.2409